PEAK6
NVO

PEAK6’s Novo Nordisk NVO Stock Holding History

PEAK6’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.5M Buy
593,600
+445,200
+300% +$19.1M 0.06% 264
2026
Q1 		$5.45M Buy
148,400
+39,900
+37% +$1.89M 0.01% 859
2025
Q4 		$5.52M Sell
108,500
-42,500
-28% -$2.17M 0.01% 899
2025
Q3 		$8.38M Buy
151,000
+21,800
+17% +$1.28M 0.01% 773
2025
Q2 		$8.92M Buy
129,200
+15,000
+13% +$1.02M 0.02% 681
2025
Q1 		$7.93M Buy
114,200
+114,100
+114,100% +$9.42M 0.02% 684
2024
Q4 		$8.6K Buy
+100
New +$10.8K ﹤0.01% 2936

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

PEAK6's NVO Position: Q2 2026 in Review

PEAK6 sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 156,695 shares — an estimated $6.73M sold.

PEAK6 first reported a position in NVO in Q4 2024 and held it in 6 quarters. The position peaked at $17.8M in Q1 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • PEAK6 reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • PEAK6 sold 156,695 Novo Nordisk shares in Q2 2026, an estimated $6.73M.
  • PEAK6 first reported a position in Novo Nordisk in Q4 2024 and held it in 6 quarters.
  • PEAK6's Novo Nordisk position peaked at $17.8M in Q1 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.